CLTR COULTER PHARMACEUTICAL Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLTR COULTER PHARMACEUTICAL

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (323)	9/26/1999 6:37:00 PM
From: rkrw	Read Replies (3) of 666

The point is that people were incredibly bullish on the run to $35 with widespread congratulatory remarks here; CLTR got delayed by an FDA decision that has, for the most part, been called BS and petty (FDA ploy amongst others) on these boards, so if they loved them at $35 are they adding here at $15? The market cap is now below LKST and just above ILXO, company's that are sharing a more limited market potential product 3 ways that will be encroached by Rituxan. Idec's rituxan is selling incredibly briskly yet there clearly remains room for a second line therapy as half rituxan users are failures. CLTR would also seem like a natural takeout candidate to me. This has probably been the most fascinating biotech story of the past few months with huge and vocal shorts; a stock which ran, got derailed; had management (very foolishly imo) lash out at the FDA and now as the stock has drifted lower and lower, silence from all involved-shorts, longs and mgt. There's some smart people here that know the story well, I'd like to know if they're taking their losses, playing it safe by hedging or going for it. If anyone was offended by the tact of my question, I offer my humble apologies.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next